NCT00601835View on ClinicalTrials.gov

Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td

PHASE4CompletedINTERVENTIONAL
Enrollment

3,651

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
DiphtheriaTetanus
Interventions
BIOLOGICAL

Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine

0.5 mL, Intramuscular, single dose

BIOLOGICAL

Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine

0.5 mL, Intramuscular, Single dose

Trial Locations (2)

15241

Pittsburgh

94611

Oakland

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00601835 - Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td | Biotech Hunter | Biotech Hunter